Signal Transduction
References
1. Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene. 2000;19:5548–5557.
2. Arkinstall S, Payton M, Maundrell K. Activation of phospholipase C in Schizosaccharomyces pombe by coexpression of receptor or nonreceptor tyrosine kinases. Mol Cell Biol. 1995;15:1431–1438.
3. Skorokhod A, Gamulin V, Gundacker D, Kavsan V, Muller IM. Origin
of insulin receptor-like tyrosine kinases in marine sponges. Biol Bull. 1999;197:198–206.
4. Collett MS, Erikson RL. Protein kinase activity associated with the avian sarcoma virus src gene product. Proc Natl Acad Sci U S A. 1978;75: 2021–2024.
5. Bazley LA, Gullick WJ. The epidermal growth factor receptor family.
Endocr Relat Cancer. 2005;12:S17–S27.
6. Eckhart W, Hutchinson MA, Hunter T. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell. 1979;18:925–933.
7. Witte ON, Dasgupta A, Baltimore D. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature. 1980;283:826–831.
8. Ushiro H, Cohen S. Identification of phosphotyrosine as a product
of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980;255:8363–8365.
9. Giancotti FG. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol. 1997;9:691–700.
10.Miettinen PJ, Berger JE, Meneses J, Phung Y, Pedersen RA, Werb Z, Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 1995;376:337–341.
11.Naccache PH, Gilbert C, Caon AC, et al. Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood. 1990;76:2098–2104.
12.Burg DL, Furlong MT, Harrison ML, Geahlen RL. Interactions of Lyn with the antigen receptor during B cell activation. J Biol Chem. 1994;269:28136–28142.
13.Cantrell DA. T cell antigen receptor signal transduction pathways. Cancer Surveys. 1996;27:165–175.
14.Williamson P, Merida I, Greene WC, Gaulton G. The membrane proximal segment of the IL-2 receptor -chain acidic region is essential for IL2dependent protein tyrosine kinase activation. Leukemia. 1994;8(suppl 1):S186–S189.
15.Kirken RA, Rui H, Evans GA, Farrar WL. Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with the IL-2 receptor -subunit. J Biol Chem. 1993;268:22765–22770.
16.Li W, Deanin GG, Margolis B, Schlessinger J, Oliver JM. Fc R1-mediated tyrosine phosphorylation of multiple proteins, including phospholipase
362
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
C 1 and the receptor 2 complex, in RBL-2H3 rat basophilic leukemia cells. Mol Cell Biol. 1992;12:3176–3182.
17.Carpenter G, King L, Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature. 1979;276:409–410.
18.Yamamoto-Honda R, Tobe K, Kaburagi Y, et al. Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. Glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras. J Biol Chem. 1995;270:2724–2729.
19.Cho HS, Mason K, Ramyar KX, et al. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 2003;421:756–760.
20.Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway 3rdKL. Insect cellexpressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci U S A. 1994;91:8132–8136.
21.Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA. Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells. J Biol Chem. 2005;280:6157–6169.
22.Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006;7:505–516.
23.Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341–354.
24.Jones RB, Gordus A, Krall JA, MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006;439:168–174.
25.Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC. TGF deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 1993;73:263–278.
26.Luetteke NC, Qiu TH, Fenton SE, et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in
mouse mammary gland development. Development. 1999;126:2739–2750.
27.Threadgill DW, Dlugosz AA, Hansen LA, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995;269:230–234.
28.Defize LH, Moolenaar WH, van der Saag PT, de Laat SW. Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies. EMBO J. 1986;5:1187–1192.
29.Spaargaren M, Defize LH, Boonstra J, de Laat SW. Antibody-induced dimerization activates the epidermal growth factor receptor tyrosine kinase. J Biol Chem. 1991;266:1733–1739.
30.Yamanaka M, Ishitani R, Nureki O, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 2002;110:775–787.
363
Signal Transduction
31.Garrett TP, McKern NM, Lou M, et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor .. Cell 2002;110:763–773.
32.Ottensmeyer FP, Beniac DR, Luo RZ, Yip CC. Mechanism of transmembrane signaling: insulin binding and the insulin receptor. Biochemistry. 2000;39:12103–12112.
33.Yip CC, Ottensmeyer P. Three-dimensional structural interactions of insulin and its receptor. J Biol Chem. 2003;278:27232–27329.
34.Brandt-Rauf PW, Rackovsky S, Pincus MR. Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function. Proc Natl Acad Sci U S A. 1990;87:8660–8664.
35.Syed RS, Reid SW, Li CW, et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 1998;395:511–516.
36.Ortega E, Schweitzer SR, Pecht I. Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells. EMBO J. 1988;7:4101–4109.
37.Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284:31–53.
38.Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T. Binding of SH2
domains of phospholipase C 1, GAP, and Src to activated growth factor receptors. Science. 1990;250:979–982.
39.Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell. 2006;125:1137–1149.
40.Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell. 2003;11:507–517.
41.Ogiso H, Ishitani R, Nureki O, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002;110:775–787.
42.Yarden Y, Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry. 1987;26:1443–1451.
43.Carter RE, Sorkin A. Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera. J Biol Chem. 2006;273:35000– 35007.
44.Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC. Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol Cell Biol. 2001;21:6387–6394.
45.Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell. 2002;110:669–672.
364
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
46.Pandiella A, Beguinot L, Velu TJ, Meldolesi J. Transmembrane signalling at epidermal growth factor receptors overexpressed in NIH 3T3 cells. Phosphoinositide hydrolysis, cytosolic Ca2 increase and alkalinization correlate with epidermal-growth-factor-induced cell proliferation,. Biochem J. 1988;254:223–228.
47.Gilligan A, Prentki M, Knowles BB. EGF receptor down-regulation attenuates ligand-induced second messenger formation. Exp Cell Res. 1990;187:134–142.
48.Gonzalez FA, Gross DJ, Heppel LA, Webb WW. Studies on the increase in cytosolic free calcium induced by epidermal growth factor, serum, and nucleotides in individual A431 cells. J Cell Physiol. 1988;135:269–276.
49.Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem. 1996;271:29342–29346.
50.Liu XQ, Pawson T. The epidermal growth factor receptor phosphorylates GTPaseactivating protein (GAP) at Tyr-460, adjacent to the GAP SH2 domains. Mol Cell Biol. 1991;11:2511–2516.
51.Medema RH, de Vries Smits AM, van der Zon GC, Maassen JA, Bos JL. Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras. Mol Cell Biol. 1993;13:155– 162.
52.Muroya K, Hattori S, Nakamura S. Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. Oncogene. 1992;7:277–281.
53.Meisenhelder J, Suh PG, Rhee SG, Hunter T. Phospholipase C is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell. 1989;57:1109–1122.
54.Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science. 1991;252:668–674.
55.Escobedo JA, Navankasattusas S, Kavanaugh WM, Milfay D, Fried VA, Williams LT. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF -receptor. Cell. 1991;65:75–82.
56.Skolnik EY, Margolis B, Mohammadi M, Lowenstein E, Fischer R, Drepps A, Ullrich A, Schlessinger J. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell. 1991;65:83–90.
57.O’Neill TJ, Craparo A, Gustafson TA. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol Cell Biol. 1994;14:6433–6442.
58.Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993;74:205–214.
365
Signal Transduction
59.Oliver SG. From gene to screen with yeast. Curr Opin Genet Dev. 1997;7:405–409.
60.Matsuda M, Mayer BJ, Fukui Y, Hanafusa H. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science. 1990;248:1537–1539.
61.Sadowski I, Stone JC, Pawson T. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol. 2006;6:4396–4408.
62.Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T. Src homology region 2 domains direct protein–protein interactions in signal transduction. Proc Natl Acad Sci U S A. 1990;87:8622–8626.
63.van der Geer P, Pawson T. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem Sci. 1995;20:277–280.
64.Kavanaugh WM, Williams LT. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 1994;266:1862–1865.
65.Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem. 1994;269:32031–32034.
66.Simons PJ, Dourmashkin RR, Turano A, Phillips DE, Chesterman FC. Morphological transformation of mouse embryo cells in vitro by murine sarcoma virus (Harvey). Nature. 1967;214:897–898.
67.Sweet RW, Yokoyama S, Kamata T, Feramisco JR, Rosenberg M, Gross M. The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature. 1984;311:273–275.
68.Chang EH, Furth ME, Scolnick EM, Lowy DR. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature. 1982;297:479– 483.
69.Feramisco JR, Gross M, Kamata T, Rosenberg M, Sweet RW. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 1984;38:109–117.
70.Feramisco JR, Clark R, Wong G, Arnheim N, Milley R, McCormick F. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature.
1985;314:639–642.
71.Satoh T, Endo M, Nakafuku M, Nakamura S, Kaziro Y. Platelet-derived growth factor stimulates formation of active p21ras, GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A. 1990;87:5993–5997.
72.Harris WA, Stark WS, Walker JA. Genetic dissection of the compound eye of Drosophila melanogaster. J Physiol. 1976;256:415–439.
73.Dickson B, Hafen E. Genetic dissection of eye development in
Drosophila. In: Bate M, Martinez-Arias A, eds. Development of Drosophila melanogaster. New York: Cold Spring Harbor Press; 2000:1327–1362.
366
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
74.Hart AC, Kramer H, Van Vactor DL, Paidhungat M, Zipursky SL. Induction of cell fate in the Drosophila retina: the bride of sevenless protein is predicted to contain a large extracellular domain and seven transmembrane segments. Genes Dev. 1990;4:1835–1847.
75.Kramer H, Cagan RL, Zipursky SL. Interaction of bride of sevenless membrane-bound ligand and the sevenless tyrosine-kinase receptor. Nature. 1991;352:207–212.
76.Hafen E, Basler K, Edstroem JE, Rubin GM. Sevenless, a cell-specific homeotic gene of Drosophila, encodes a putative transmembrane receptor with a tyrosine kinase domain. Science. 1987;236:55–63.
77.Fortini ME, Simon MA, Rubin GM. Signalling by the sevenless protein tyrosine kinase is mimicked by Ras1 activation. Nature. 1992;355:559– 561.
78.Jones S, Vignais M-L, Broach JR. The CDC25 protein of S.cerevisiae promotes exchange of guanine nucleotides bound to ras. Mol Cell Biol. 1991;11:2641–2646.
79.Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domaincontaining protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431–442.
80.Kornfeld K. Vulval development in Caenorhabditis elegans. Trends Genet. 1997;13:55–61.
81.Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 2006;12:824–828.
82.Gale NW, Kaplan S, Lowenstein EJ, Schlessinger J, Bar-Sagi D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature. 1993;363:88–92.
83.Stern MJ, Marengere LE, Daly RJ, et al. The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5. Mol Biol Cell. 1993;4:1175–1188.
84.Li N, Batzer A, Daly R, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature. 1993;363:85–88.
85.Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J, Karin M. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell. 1994;78:949–961.
86.Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature. 1993;363:83–85.
87.Yang SS, Van Aelst L, Bar-Sagi D. Differential interactions of human Sos1 and Sos2 with Grb2. J Biol Chem. 1995;270:18212–18215.
88.Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb2-associated docking, protein in EGFand insulin-receptor signalling. Nature. 1996;379:560–564.
367
Signal Transduction
89. Burgering BM, Freed E, van der Voorn L, McCormick F, Bos JL. Platelet-derived growth factor-induced p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or phosphatidylinositol-3-kinase. Cell Growth Differ. 1994;5:341–347.
90. Ray LB, Sturgill TW. Rapid stimulation by insulin of a serine/threonine kinase in 3T3L1 adipocytes that phosphorylates microtubuleassociated protein 2 in vitro. Proc Natl Acad Sci U S A. 1987;84:1502–1506.
91. Dumaz N, Light Y, Marais R. Cyclic AMP blocks cell growth through
Raf-1-dependent and Raf-1-independent mechanisms. Mol Cell Biol. 2002;22:3717–3728.
92. Duesbery NS, Webb CP, Leppla SH, et al. Proteolytic inactivation of MAP- kinase-kinase by anthrax lethal factor. Science. 1998;280:734–737.
93. Bhatt RR, Ferrell Jr JE. Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs. J Biol Chem. 2000;275:32983–32990.
94. Chen Z, Gibson TB, Robinson F, et al. MAP kinases. Chem Rev. 2001;101:2449–2476.
95. Rapp UR, Goldsborough MD, Mark GE, et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci U S A. 1983;80:4218–4222.
96. Moodie SA, Willumsen BM, Weber MJ, Wolfman A. Complexes of Ras. GTP with Raf-1 and mitogen-activated protein kinase kinase. Science. 1993;260:1658–1661.
97. Warne PH, Viciana PR, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature. 1993;364:352–355.
98. Koide H, Satoh T, Nakafuku M, Kaziro Y. GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells. Proc Natl Acad Sci U S A. 1993;90:8683–8686.
99. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 1994;369:411–414.
100.Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science. 1994;264:1463–1467.
101.Mineo C, Anderson RG, White MA. Physical association with ras enhances activation of membrane-bound raf (RafCAAX). J Biol Chem. 1997;272:10345–10348.
102.Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ ERK pathway by protein interactions. Biochem J. 2000;351(Pt 2):289–305.
103.Ory S, Zhou M, Conrads TP, Veenstra TD, Morrison DK. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol. 2003;13:1356–1364.
368
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
104.Hekman M, Wiese S, Metz R, et al. Dynamic changes in C-Raf phosphorylation and 14-3-3 protein binding in response to growth factor stimulation: differential roles of 14-3-3 protein binding sites. J Biol Chem. 2004;279:14074–14086.
105.Rapp UR, Goldsborough MD, Mark GE, et al. Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci U S A. 1983;80:4218–4222.
106.Jansen HW, Ruckert B, Lurz R, Bister K. Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus MH2. EMBO J. 1983;2:1969–1975.
107.Wellbrock C, Karasarides M, Marais R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875–885.
108.Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–954.
109.Wan PT, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116:855–867.
110.Kallunki T, Su B, Tsigelny I, et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 1994;8:2996–3007.
111.Kallunki T, Deng T, Hibi M, Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 1996;87:929–939.
112.Masuda K, Shima H, Katagiri C, Kikuchi K. Activation of ERK induces phosphorylation of MAPK phosphatase-7, a JNK specific phosphatase, at Ser-446. J Biol Chem. 2003;278:32448–32456.
113.Vinciguerra M, Vivacqua A, Fasanella G, et al. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J Biol Chem. 2004;279:9634–9641.
114.Tanoue T, Adachi M, Moriguchi T, Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol. 2000;2:110–116.
115.Brunet A, Pouyssegur J. Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science. 1996;272:1652–1655.
116.Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 1997;90:859–869.
117.Dimitri CA, Dowdle W, MacKeigan JP, Blenis J, Murphy LO. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo. Curr Biol. 2005;15:1319–1324.
118.Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68:320–344.
369
Signal Transduction
119.Hauge C, Frodin M. RSK and MSK in MAP kinase signalling. J Cell Sci. 2006;119:3021–3023.
120.Erikson E, Maller JL. A protein kinase from Xenopus eggs specific for ribosomal protein S6. Proc Natl Acad Sci U S A. 1985;82:742–746.
121.Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 1997;16:1909–1920.
122.Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, LawrenceJC J. PHAS-I as a link between mitogen-activated protein kinase and translation initiation [see comments]. Science. 1994;266:653–656.
123.Sonenberg N, Gingras AC. The mRNA 5’ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol. 1998;10:268–275.
124.Cuesta R, Xi Q, Schneider RJ. Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J. 2000;19:3465–3474.
125.Kruijer W, Cooper JA, Hunter T, Verma IM. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature. 1984;312:711–716.
126.Adachi M, Fukuda M, Nishida E. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimmer. EMBO J. 1999;18:5347–5358.
127.Adachi M, Fukuda M, Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol. 2000;148:849–856.
128.Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996;8:205–215.
129.Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol. 2002;4:556–564.
130.Murphy LO, MacKeigan JP, Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol. 2004;24:144–153.
131.Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D. A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature. 1983;306:395–397.
132.de Taisne C, Gegonne A, Stehelin D, Bernheim A, Berger R. Chromosomal localization of the human proto-oncogene c-ets. Nature. 1984;310:581–583.
133.Sternberg MJ, Gullick WJ. Neu receptor dimerization. Nature. 1990;339:587.
134.Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene. 1994;9:59–70.
135.Gupta S, Seth A, Davis RJ. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A. 1993;90:3216–3220.
370
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
136.Oskarsson T, Trumpp A. The Myc trilogy: lord of RNA polymerases. Nat Cell Biol. 2005;7:215–217.
137.Whitmarsh AJ, Davis RJ. A central control for cell growth. Nature. 2000;403:255–256.
138.Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol. 1999;19:321–329.
139.Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. E. EMBO J. 2000;19:2056–2068.
140.Herber B, Truss M, Beato M, Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994;9:2105–2107.
141.Ladha MH, Lee KY, Upton TM, Reed MF, Ewen ME. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol Cell Biol. 1998;18:6605–6615.
142.Suzuki T, Tsuzuku J, Ajima R, Nakamura T, Yoshida Y, Yamamoto T. Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev. 2002;16:1356–1370.
143.Lee WH, Shew JY, Hong FD, Sery TW, Young LJ, Bookstein R, Lee EY. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987;329:642–645.
144.Graves LM, Guy HI, Kozlowsk P, et al. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature. 2000;403:328–332.
145.Pages G, Brunet A, L’Allemain G, Pouyssegur, J. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1). EMBO J. 1994;13:3003–3010.
146.Kahan C, Seuwen K, Meloche S, Pouyssegur J. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J Biol Chem. 1992;267:13369–13375.
147.Aplin AE, Stewart SA, Assoian RK, Juliano RL. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol. 2001;153:273–282.
148.Choi KY, Satterberg B, Lyons DM, Elion EA. Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae. Cell. 1994;78:499–512.
149.Elion EA. The Ste5p scaffold. J Cell Sci. 2001;114:3967–3978.
150.Lamson RE, Takahashi S, Winters MJ, Pryciak PM. Dual role for membrane localization in yeast MAP kinase cascade activation and its contribution to signaling fidelity. Curr Biol. 2006;16:618–623.
151.Bhattacharyya RP, Remenyi A, Good MC, Bashor CJ, Falick AM, Lim WA. The Ste5 scaffold allosterically modulates signaling output of the yeast mating pathway. Science. 2006;311:822–826.
371
Signal Transduction
152.Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol. 2005;6:827–837.
153.Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA, Rubin GM. KSR, a novel protein kinase required for RAS signal transduction. Cell. 1995;83:879–888.
154.Therrien M, Michaud NR, Rubin GM, Morrison DK. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 1996;10:2684–2695.
155.Kornfeld K, Hom DB, Horvitz HR. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell. 1995;83:903–913.
156.Nguyen A, Burack WR, Stock JL, et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol. 2002;22:3035–3045.
157.Stewart S, Sundaram M, Zhang Y, Lee J, Han M, Guan KL. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol Cell Biol. 1999;19:5523–5534.
158.Morrison DK. KSR: a MAPK scaffold of the Ras pathway? J Cell Sci 2001;114:1609–1612.
159.Muller J, Ory S, Copeland T, Piwnica-Worms H, Morrison DK. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol Cell. 2001;8:983–993.
160.Matheny SA, Chen C, Kortum RL, Razidlo GL, Lewis RE, White MA. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature. 2004;427:256–260.
161.Lozano J, Xing R, Cai Z, et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res. 2003;63:4232– 4238.
162.Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401:173–177.
163.Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem. 2003;278:13061–13068.
164.Luttrell LM, Lefkowitz RJ. The role of -arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002;115:455–465.
165.Wunderlich W, Fialka I, Teis D, et al. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment. J Cell Biol. 2001;152:765–776.
166.Teis D, Wunderlich W, Huber LA. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell. 2002;3:803–814.
167.Wiley HS, Shvartsman SY, Lauffenburger DA. Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol. 2003;13:43–50.
372
Signalling Pathways Operated by Receptor Protein Tyrosine Kinases
168.Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol. 2002;20:370–375.
169.Buday L, Warne PH, Downward J. Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos. Oncogene. 1995;11:1327–1331.
170.Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D. Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol. 1996;16:
5674–5682.
171.Wang Z, Moran MF. Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science. 1996;272:1935–1939.
172.Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006;7:505–516.
173.Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005;24:3353–3359.
174.Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991;353:670–674.
175.Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoproteinand UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993;7:2135–2148.
176.Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807–869.
177.Kyriakis JM, Avruch J. pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J Biol Chem. 1990;265:17355–17363.
178.Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev. 2002;12:14–21.
179.Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC. An osmosensing signal transduction pathway in yeast. Science. 1993;259:1760–1763.
180.Albertyn J, Hohmann S, Thevelein JM, Prior BA. GPD1, which encodes glycerol-3-phosphate dehydrogenase, is essential for growth under osmotic stress in Saccharomyces cerevisiae, and its expression is regulated by the high-osmolarity glycerol response pathway. Mol Cell Biol. 1994;14:4135–4144.
181.Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006;7:782–786.
182.Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding ras: ‘It ain’t over ‘til it’s over’. Trends Cell Biol. 2000;10:147–154.
183.Whitmarsh AJ, Davis RJ. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem Sci. 1998;23:481–486.
373
Signal Transduction
184.Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M. Plateletderived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol. 1996;16:1759–1769.
185.Zhong Z, Wen Z, Darnell JEJ. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264:95–98.
186.Wagner BJ, Hayes TE, Hoban CJ, Cochran BH, Doolittle RF. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 1990;9:4477–4484.
187.Doolittle RF, Hunkapiller MW, Hood LE, et al. Simian sarcoma virus oncogene, v-sis, is derived from the gene (or genes) encoding a plateletderived growth factor. Science. 1983;221:275–277.
188.Blaukat A, Barac A, Cross MJ, Offermanns S, Dikic I. G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of G q and G i signals. Mol Cell Biol. 2000;20:6837–6848.
189.Schmitt JM, Stork PJ. G and G require distinct Src-dependent pathways to activate Rap1 and Ras. J Biol Chem. 2002;277:43024–43032.
190.Hall RA, Premont RT, Lefkowitz RA. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol. 1999;145:927–932.
191.Kranenburg O, Verlaan I, Hordijk PL, Moolenaar WH. Gi mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosinephosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO J. 1997;16:3097–3105.
192.Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 1997;16:7032–7044.
193.Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884–888.
194.Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K, Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem. 1997;272:24767–24770.
195.Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002;8:289–293.
196.Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci. 2003;74:143–153.
197.Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of -arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A. 2006;103:1492–1497.
198.Wang D, DuBois RN. Prostaglandins and cancer. Gut. 2006;55:115–122.
374